Advanced search
Publication Cover
Drug, Healthcare and Patient Safety Volume 7, 2015 - Issue
Submit an article Journal homepage
58
Views
8
CrossRef citations to date
0
Altmetric
Original Research

Safety profile of dalfampridine extended release in multiple sclerosis: 5-year postmarketing experience in the United States

Michele JaraAcorda Therapeutics, Inc., Ardsley, NY, USACorrespondence[email protected]
,
Thomas AquilinaAcorda Therapeutics, Inc., Ardsley, NY, USA
,
Peter AupperleAcorda Therapeutics, Inc., Ardsley, NY, USA
&
Adrian L RabinowiczAcorda Therapeutics, Inc., Ardsley, NY, USA
Pages 169-174 | Published online: 15 Dec 2015

Reprints and Permissions

Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.

To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.

Order Reprints Request Permissions

For more information please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.